{"title":"治疗中断的年龄小，足月出生的儿童","authors":"A. Frascino, L. Cominato","doi":"10.25753/BIRTHGROWTHMJ.V29.I1.15101","DOIUrl":null,"url":null,"abstract":"Small-for-gestational-age children have been associated with up to 20% delayed growth and delayed development, increased childhood morbimortality, and poor quality of life. Prepubertal growth hormone administration results in increased growth and musculoskeletal development. The present case report illustrates the negative impact of growth hormone disruption in a 6-year-old patient, resulting in impaired growth and development. Close clinical and laboratory monitoring is recommended for small-for-gestational-age children receiving growth hormone treatment, and family counselling should be encouraged.","PeriodicalId":31313,"journal":{"name":"Nascer e Crescer","volume":"15 1","pages":"47-50"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment interruption in small for age term-born children\",\"authors\":\"A. Frascino, L. Cominato\",\"doi\":\"10.25753/BIRTHGROWTHMJ.V29.I1.15101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Small-for-gestational-age children have been associated with up to 20% delayed growth and delayed development, increased childhood morbimortality, and poor quality of life. Prepubertal growth hormone administration results in increased growth and musculoskeletal development. The present case report illustrates the negative impact of growth hormone disruption in a 6-year-old patient, resulting in impaired growth and development. Close clinical and laboratory monitoring is recommended for small-for-gestational-age children receiving growth hormone treatment, and family counselling should be encouraged.\",\"PeriodicalId\":31313,\"journal\":{\"name\":\"Nascer e Crescer\",\"volume\":\"15 1\",\"pages\":\"47-50\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nascer e Crescer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25753/BIRTHGROWTHMJ.V29.I1.15101\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nascer e Crescer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25753/BIRTHGROWTHMJ.V29.I1.15101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment interruption in small for age term-born children
Small-for-gestational-age children have been associated with up to 20% delayed growth and delayed development, increased childhood morbimortality, and poor quality of life. Prepubertal growth hormone administration results in increased growth and musculoskeletal development. The present case report illustrates the negative impact of growth hormone disruption in a 6-year-old patient, resulting in impaired growth and development. Close clinical and laboratory monitoring is recommended for small-for-gestational-age children receiving growth hormone treatment, and family counselling should be encouraged.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
